Skip to main content

Diabetes

  • Amylin seeks FDA approval for metreleptin

    SAN DIEGO — Drug maker Amylin Pharmaceuticals has filed for regulatory approval of a drug to treat diabetes and elevated triglycerides in the bloodstream in children and adults with a rare disorder.

  • Marsh Supermarkets launches diabetes education program

    INDIANAPOLIS — Marsh Supermarkets on Tuesday recognized National Public Health Week with the introduction of a program to help people with diabetes better understand, manage and live with the disease — more than 9% of Indiana residents have been diagnosed with diabetes, the grocer noted.

  • FDA OKs Levemir for pregnant women

    NEW YORK — A diabetes treatment made by Novo Nordisk is safe for pregnant women, according to a recent decision by the Food and Drug Administration.

    Novo Nordisk said Monday the FDA had approved Levemir (insulin detemir [rDNA origin]) for a pregnancy category B classification, meaning that when used by pregnant women, the insulin did not increase the risk of harm to fetuses. The agency's decision was based on results of a clinical trial involving 310 women that compared Levemir to another insulin product.

    The insulin is used to treat Type 1 and Type 2 diabetes.

  • Metformin may help slow progression, reduce risk of certain cancers

    NEW YORK — A medication commonly prescribed for patients with Type 2 diabetes also may play a critical role in patients at risk of developing certain cancers.

    In three separate studies published in Cancer Prevention Research, a journal of the American Association for Cancer Research, findings showed how metformin may protect against oral cancer and liver cancer, as well as slow the growth rate of prostate cancer among men prior to prostatectomy.

  • Daiichi Sankyo, NGM to develop diabetes drugs

    SOUTH SAN FRANCISCO, Calif. — Daiichi Sankyo and NGM Biopharmaceuticals said they signed a research and licensing agreement to develop treatments for Type 1 and Type 2 diabetes. The drugs would work by reviving beta cells, the decline of which contributes to the disease.

  • American Diabetes Association debuts new diabetes risk test

    ALEXANDRIA, Va. — In line with the 24th annual American Diabetes Association Alert Day, the American Diabetes Association debuted its new and improved diabetes risk test.

  • Study suggests metformin may help prevent heart disease

    NEW YORK — A commonly prescribed diabetes drug also may have the capability of protecting the heart, according to a Swedish study.

  • Walgreens, National Urban League partner on Way to Well Health Tour

    DEERFIELD, Ill. — Walgreens and the National Urban League on Wednesday launched the Walgreens Way to Well Health Tour with National Urban League as a charitable component of the Walgreens Way to Well Commitment. The national tour provides free health resources to residents in urban and minority communities who experience disproportionately higher rates of preventable diseases, the companies stated. The service is free and insurance will not be billed.

X
This ad will auto-close in 10 seconds